Research to Advance and Further Validate Microarray-Based Blood Test for Pre-Symptomatic Detection of Ovarian Cancer HOUSTON — Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC – News), today announced that it has executed a sponsored research agreement with Wayne State University and Arrayit Corporation, which encompasses continuing research and development […]
Proprietary Molecular-Based Cervical Cancer Test oncoFISH® Cervical Available For Cervical Cytology Evaluation NEW YORK–Enzo Biochem, Inc. (NYSE:ENZ) announced today that its Enzo Clinical Lab division has entered into an exclusive marketing partnership covering the States of New York and New Jersey with privately-owned Ikonisys, Inc., of New Haven, CT, relating to Ikonisys’ proprietary oncoFISH® cervical […]
CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae – New cobas(R) 4800 System designed to increase laboratory efficiency and medical value PLEASANTON, Calif. — Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of a new clinical laboratory system designed to increase laboratory testing efficiency and to accommodate current and […]
Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics – Signs License Agreement with Wayne State University For Exclusive Worldwide Rights to Ovarian Cancer Biomarkers HOUSTON — Arrayit Diagnostics, Inc., a majority-owned subsidiary of Arrayit Corporation (OTC Bulletin Board: ARYC – News), today announced that it has signed an exclusive […]
To Develop Real-Time Imaging Agents for Prostate and Ovarian Cancer Surgery Lincoln, Nebraska/Portola Valley, California: LI-COR Biosciences and Spectros Corporation announce a non-exclusive licensing and supply agreement to couple LI-COR Biosciences’ IRDye® 800CW to Spectros’ proprietary targeted biomarkers, and to develop the targeted fluorescent contrast agents for the real-time imaging and treatment of prostate and […]
High sensitivity research-use kit for broad detection of mutations predictive of response to recently developed therapies OMAHA, Neb. — Transgenomic, Inc. (OTC BB: TBIO.OB) announced today the launch of its SURVEYOR Scan K-RAS kit, the first in a family of mutation detection kits the company plans to offer featuring its proprietary SURVEYOR Nuclease and WAVE® […]
Facility makes it easier for west-coast lab personnel to get hands-on experience with analyzers INDIANAPOLIS — Roche Diagnostics announced today the opening of a new west-coast customer training center in Pleasanton, California, as part of an initiative to make state-of-the-art training on diagnostic equipment more accessible to hospitals and independent laboratories on the west and […]
Collaboartion to Develop Microchip Diagnostics Based on Engineered Peptides Partnership Represents the First Step in Realizing Potential Diagnostic Applications for C3-Jian Engineered Peptides, Acting as an Antibody Replacement, on the Matrix Sensors Platform PLEASANTON, CA– C3-Jian, Inc. and Matrix Sensors, Inc. have announced a collaboration in which engineered peptides from C3-Jian will be used on […]
SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM – News), today announced that Dr. Yves Ville has joined the company’s Clinical Advisory Board. Dr. Ville is a prominent obstetrician-gynecologist and currently serves as professor and chairman of the department of obstetrics and fetal medicine at Necker-Enfants-Malades Hospital at the Paris Descartes University. (Logo: https://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO) “I am […]
PENZBERG, Germany–The Roche assay for the 2009 H1N1 influenza virus detects RNA from the 2009 H1N1 Influenza A virus and provides a rapid means of identification of patients infected with this virus. In order to ensure continued specificity and sensitivity of the Roche’s Influenza A/H1N1 assay, Roche performs sequence comparisons with all available 2009 H1N1 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
